Long-term credibility depends on scientific restraint
A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin
This likely contributes to GHK-Cus cardiovascular and tissue protective effects
NO completed peer-reviewed trials for individual peptides Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite extensive preclinical research on individual peptides, the BPC-157 + TB-500 combination faces substantial translational barriers that severely limit its research utility and prevent any clinical application
It connects to the broader Anti-Aging & Functional Medicine Academy and to the complete IV Nutrition Therapy resource center for providers building or expanding a wellness-infusion practice responsibly
Yes, always practice aseptic technique, including using sterile gloves and disinfecting the injection site